Insider Transactions in Q2 2024 at Palisade Bio, Inc. (PALI)
Insider Transaction List (Q2 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 11
2024
|
Donald Allen Williams Director |
BUY
Exercise of conversion of derivative security
|
Direct |
340
+50.0%
|
-
|
Jun 11
2024
|
Binxian Wei Director |
BUY
Exercise of conversion of derivative security
|
Direct |
465
+49.89%
|
-
|
May 28
2024
|
John David Finley CEO, CFO, Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,033
-5.46%
|
$8,132
$4.76 P/Share
|
May 28
2024
|
John David Finley CEO, CFO, Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,068
+15.81%
|
-
|
May 28
2024
|
Mitchell Lawrence Jones Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,271
-16.7%
|
$5,084
$4.76 P/Share
|
May 28
2024
|
Mitchell Lawrence Jones Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,290
+34.95%
|
-
|
May 28
2024
|
Donald Allen Williams Director |
BUY
Open market or private purchase
|
Direct |
1,000
+50.0%
|
$4,000
$4.86 P/Share
|
May 24
2024
|
John David Finley CEO, CFO, Director |
BUY
Open market or private purchase
|
Direct |
1,000
+10.6%
|
$4,000
$4.81 P/Share
|
May 20
2024
|
John David Finley CEO, CFO, Director |
BUY
Grant, award, or other acquisition
|
Direct |
666
+8.22%
|
$2,664
$4.97 P/Share
|
May 06
2024
|
John David Finley CEO, CFO, Director |
SELL
Payment of exercise price or tax liability
|
Direct |
128
-0.95%
|
$1,024
$8.46 P/Share
|
May 06
2024
|
John David Finley CEO, CFO, Director |
BUY
Exercise of conversion of derivative security
|
Direct |
443
+3.17%
|
-
|
May 06
2024
|
Mitchell Lawrence Jones Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
137
-8.2%
|
$1,096
$8.46 P/Share
|
May 06
2024
|
Mitchell Lawrence Jones Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
460
+21.12%
|
-
|